From Scalpel to Stage, Stocks Strumming Into the Close

October 22, 2025

DENVER, Colo., Oct 22, 2025 (247marketnews.com)- As the clock ticks into the final hour of trading, momentum is building across sectors. These stocks to watch are making noise into the close and beyond.

GSI Technology (NASDAQ:GSIT) exploded this week after Cornell University validated its Gemini-I APU, proving that compute-in-memory isn’t a concept, it’s a real challenge to GPU incumbents.

  • Gemini-I matched NVIDIA’s A6000 GPU in AI inference benchmarks
  • Delivered >98% energy efficiency gains
  • Ran 80% faster than traditional CPUs on some tasks
  • Backed by a fresh $50M direct offering at $10/share to a single institutional investor

CEO Lee-Lean Shu said, “Cornell’s independent validation confirms what we’ve long believed — compute-in-memory has the potential to disrupt the $100 billion AI inference market.”

Watch GSIT for post-market commentary and institutional flow.

While under the radar today, Armata Pharmaceuticals (NYSE:ARMP) is gathering interest among biotech speculators following recent BARDA updates and the increased focus on phage therapies as an alternative to antibiotics. Armata’s lead candidate AP-PA02 targets multi-drug resistant Pseudomonas, a growing concern in critical care.

Analysts continue to eye ARMP’s platform in light of increased antimicrobial resistance funding. No major headlines yet today, but the stock is riding higher alongside broader infectious disease names. Any update could trigger sharp movement.

Intuitive Surgical (NASDAQ:ISRG) is ripping higher after delivering a surgical earnings beat:

  • Revenue: $2.51B, up 23% YoY
  • Net Income: $704M GAAP / $867M Non-GAAP
  • da Vinci procedure growth +13%
  • $1.92B in stock buybacks in Q3

CEO Dave Rosa highlighted ongoing strength across both da Vinci and Ion platforms and reaffirmed a 17% growth target for 2025.

Robotic surgery is now a scale game, and ISRG just reminded the market why it’s still the king of the OR.

Pegasystems (NASDAQ:PEGA) hasn’t moved significantly today, but the workflow automation firm remains a sleeper AI play heading into earnings. With enterprises investing in low-code and real-time decisioning, PEGA’s Pega Infinity platform and AI-powered case management tools are gaining ground in public sector and financial verticals.

Expect renewed attention as larger automation firms report later this week. Watch for a sympathy move.

Vicor Corporation (NASDAQ:VICR) designs high-performance power modules critical to powering advanced processors, including AI accelerators and data center GPUs. With GSIT, AMD, and NVIDIA all in focus, VICR becomes the picks-and-shovels bet on hardware.

The company reports earnings next week, and traders are beginning to position early.

Winnebago Industries (NYSE:WGO) has seen rising volume today amid signs of a resilient high-end RV market. With gas prices easing and consumer discretionary data showing strength, Winnebago could benefit from the ongoing “premium lifestyle economy.”

Analysts are looking for upside surprises in margin performance and segment diversification. A short squeeze potential is building, with short interest rising into earnings.

Travel + Leisure Co. (NYSE:TNL) is seeing light upward pressure today as consumer travel remains strong. Expect focus on:

  • Booking volumes for 2026 travel packages
  • Continued recovery in international destinations
  • Resilience in vacation ownership models

Investors are eyeing next week’s earnings for forward bookings and any impact from recent global conflict tensions.

VENU’s (NYSE:VENU) Annual Shareholder Meeting on October 28 is becoming one of the most creative investor relations moves on Wall Street. The Marshall Tucker Band private concert is grabbing attention, but it’s the numbers that hit high notes:

  • $23M in FireSuite sales in just 60 days
  • $5B development pipeline
  • $1.3B currently under construction

Stock price? Still trading below $2, cheaper than a concert ticket.

Analysts agree:

  • Cenorium: Buy, $22.30 PT
  • ThinkEquity: Buy, $18 PT

With experiential entertainment rebounding, VENU may become the venue stock for long-term growth.

Please click here to read Cenorium’s full Venu analyst report on 247marketnews.com.

For the full 24/7 Market News VENU report and in-depth insights, including analyst reports, visit: Read 24/7 Market News VENU Report/

Contact sales@247marketnews.com for Analyst Report coverage and other investor/public relations services.

24/7 MARKET NEWS, INC (247) Disclaimer and Disclosure
PAID EDITORIAL DISCLOSURE: 247MarketNews.com has been compensated $2,500 per week by MicroCap Strategies for ongoing press and editorial coverage of VENU. This is a paid editorial communication intended for informational purposes only. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. This press release may include technical analysis for informational purposes only and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please go to https://247marketnews.com/venu-disclosure/ for additional 247marketnews.com VENU disclosure information.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (VENU, PEGA, WGO, TNL, VICR, ISRG)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.